The Concept of Epigenetics and Its Role in the Development of Cardiovascular Disease: Commentary on “New and Emerging Theories of Cardiovascular Disease”
Restricted accessResearch articleFirst published online July, 2004
The Concept of Epigenetics and Its Role in the Development of Cardiovascular Disease: Commentary on “New and Emerging Theories of Cardiovascular Disease”
Alpert PT. 2004. Newand emerging theories of cardiovascular disease: infection and elevated iron are two postulated theories. Biol Res Nurs6:3-10.
2.
Argeson AC, Nelson KK, Siracusa LD. 1996. Molecular basis of the pleiotropic phenotype of mice carrying the hypervariable yellow (Ahvy) mutation at the agouti locus. Genetics142:557-567.
3.
Armenante F, Merola M, Furia A, Palmieri M. 1999. Repression of the IL-6 gene is associated with hypermethylation. Biochem Biophys Res Commun258:644-647.
4.
Asch BB, Barcellos-Hoff MH. 2001. Epigenetics and breast cancer. J Mammary Gland Biol Neoplasia6:151-152.
5.
Bariol C, Suter C, Cheong K, Ku SL, Meagher A, Hawkins N, Ward R. 2003. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol162:1361-1371.
6.
Barker DJ. 1997. Intrauterine programming of coronary heart disease and stroke. Acta PaediatrSuppl 423:178-182.
7.
Barker DJ, Osmond C, Simmonds SJ, Wield GA. 1993. The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ306:422-426.
8.
Barrett-Connor E, KhawK. 1984. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation69:1065-1069.
9.
Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA274:1049-1057.
10.
Carrozza MJ, Utley RT, Workman JL, Cote J. 2003. The diverse functions of histone acetyltransferase complexes. Trends Genet19:321-329.
11.
Cedar H. 1988. DNA methylation and gene activity. Cell53:3-4.
12.
Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, ChenMF, Pai A, JohnSW, Smith RS, and others. 2001. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet10:433-443.
13.
Cooney CA. 1993. Are somatic cells inherently deficient in methylation metabolism? A proposed mechanism for DNA methylation loss, senescence and aging. Growth Dev Aging57:261-273.
Evans A, Van Baal GC, McCarron P, DeLange M, Soerensen TI, De Geus EJ, Kyvik K, Pedersen NL, Spector TD, Andrew T, and others. 2003. The genetics of coronary heart disease: the contribution of twin studies. Twin Res6:432-441.
16.
Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M. 1988. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res48:1159-1161.
17.
Felsenfeld G, Groudine M. 2003.Controlling the double helix. Nature421:448-453.
18.
Finkelstein JD, Martin JJ. 2000. Homocysteine. Int J Biochem Cell Biol32:385-389.
19.
Friedlander Y, Siscovick DS, Arbogast P, Psaty BM, Weinmann S, Lemaitre RN, Raghunathan TE, Cobb LA. 2002. Sudden death and myocardial infarction in first degree relatives as predictors of primary cardiac arrest. Atherosclerosis162:211-216.
Holliday R. 1998. The possibility of epigenetic transmission of defects induced by teratogens. Mutat Res422:203-205.
23.
Holliday R, Ho T, Paulin R. 1996. Gene silencing in mammalian cells. In: Russo VEA, Martienssen RA, Riggs AD, editors. Epigenetic mechanisms of gene regulation. Plainview (NY): Cold Spring Harbor Laboratory Press. p 47-59.
24.
Irvine RA, Lin IG, Hsieh CL. 2002. DNA methylation has a local effect on transcription and histone acetylation. Mol Cell Biol22:6689-6696.
25.
Issa JP. 2000. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol249:101-118.
26.
Jablonka E, Lamb MJ. 2002. The changing concept of epigenetics. Ann N Y Acad Sci981:82-96.
27.
Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet33Suppl:245-254.
28.
Jeppesen P. 1997. Histone acetylation: a possible mechanism for the inheritance of cell memory at mitosis. Bioessays19:67-74.
29.
Jones AP, Assimon SA, Friedman MI. 1986. The effect of diet on food intake and adiposity in rats made obese by gestational undernutrition. Physiol Behav37:381-386.
30.
Kondo Y, Issa JP. 2003. Enrichment for histone H3 lysine 9 methylation at Alu repeats in human cells. J Biol Chem278:27658-27662.
31.
Lamb MJ. 1994. Epigenetic inheritance and aging. Rev Clin Gerontol4:97-105.
32.
Maier S, Olek A. 2002. Diabetes: a candidate disease for efficient DNA methylation profiling. J Nutr132:2440S-2443S.
33.
McCully KS. 1969. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol56:111-128.
34.
Mielnicki LM, Asch HL, Asch BB. 2001. Genes, chromatin, and breast cancer: an epigenetic tale. J Mammary Gland Biol Neoplasia6:169-182.
Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature393:386-389.
39.
Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, Graff JR. 2000. Aberrant methylation of the estrogen receptor and E-cadherin 5’ CpG islands increases with malignant progression in human breast cancer. Cancer Res60:4346-4348.
40.
Newberne PM. 1986. Lipotropic factors and oncogenesis. Adv Exp Med Biol206:223-251.
41.
Nomura T. 1982. Parental exposure to x rays and chemicals induces heritable tumours and anomalies in mice. Nature296:575-577.
42.
Oppenheim EW, Adelman C, Liu X, Stover PJ. 2001. Heavy chain ferritin enhances serine hydroxymethyltransferase expression and de novo thymidine biosynthesis. J Biol Chem276:19855-19861.
43.
Petronis A. 2001. Human morbid genetics revisited: relevance of epigenetics. Trends Genet17:142-146.
44.
Petronis A, Petroniene R. 2000. Epigenetics of inflammatory bowel disease. Gut47:302-306.
45.
Poirier LA, Brown AT, Fink LM, Wise CK, Randolph CJ, Delongchamp RR, Fonseca VA. 2001. Blood Sadenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy. Metabolism50:1014-1018.
46.
Poirier LA, Wise CK, Delongchamp RR, Sinha R. 2001. Blood determinat ions of S-adenosylmethionine, Sadenosylhomocysteine, and homocysteine: correlations with diet. Cancer Epidemiol Biomarkers Prev10:649-655.
47.
Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, Ouyang P, Milliken EE, Issa JP. 1999. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res43:985-991.
48.
Rada C, Ferguson-Smith AC. 2002. Epigenetics: monoallelic expression in the immune system. Curr Biol12:R108-R110.
49.
Retterstol L, Paus B, Bohn M, Bakken A, Erikssen J, MalinowMR, Berg K. 2003. Plasma total homocysteine levels and prognosis in patients with previous premature myocardial infarction: a 10-year follow-up study. J Intern Med253:284-292.
50.
Rich-Edwards JW, Stampfer M, Manson J, Rosner B, Colditz G, WillettW. 1995. Birthweight, breastfeeding and the risk of coronary heart disease in the nurse’s health study [abstract]. Am J Epidemiol141: S78-S78.
51.
Rissanen AM. 1979. Familial aggregation of coronary heart disease in a high incidence area (North Karelia, Finland). Br Heart J42:294-303.
52.
Ross R. 1999. Atherosclerosis—an inflammatory disease. N Engl J Med340:115-126.
53.
Selhub J, Jacques PF, Bostom AG, D’Agostino RB, Wilson PW, Belanger AJ, O’Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. 1995. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med332:286-291.
54.
Siegmund KD, Province MA, Higgins M, Williams RR, Keller J, Todorov AA. 1998. Modeling disease incidence rates in families. Epidemiology9:557-562.
55.
Sobel RE, Cook RG, Perry CA, Annunziato AT, Allis CD. 1995. Conservation of deposition-related acetylation sites in newly synthesized histones H3 and H4. Proc Natl Acad Sci U S A92:1237-1241.
Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. 1993. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest91:308-318.
58.
Stover PJ, Garza C. 2002. Bringing individuality to public health recommendations. J Nutr132:2476S-2480S.
59.
Takei S, Fernandez D, Redford A, Toyoda H. 1996. Methylation status of 5•-regulatory region of tumor necrosis factor alpha gene correlates with differentiation stages of monocytes. Biochem Biophys Res Commun220:606-612.
60.
Tofler GH, D’Agostino RB, Jacques PF, Bostom AG, Wilson PW, Lipinska I, Mittleman MA, Selhub J. 2002. Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk. Thromb Haemost88:799-804.
61.
Toyooka S, Toyooka KO, Miyajima K, Reddy JL, Toyota M, Sathyanarayana UG, Padar A, Tockman MS, Lam S, Shivapurkar N, and others. 2003. Epigenetic down-regulation of death-associated protein kinase in lung cancers. Clin Cancer Res9:3034-3041.
62.
Verma M, Srivastava S. 2002. Epigenetics in cancer: implications for early detection and prevention. Lancet Oncol3:755-763.
63.
Vidali G, Ferrari N, Pfeffer U. 1988. Histone acetylation: a step in gene activation. Adv Exp Med Biol231:583-596.
64.
Waeber B, Brunner HR. 2001. The multifactorial nature of hypertension: the greatest challenge for its treatment?J Hypertens Suppl19Suppl 3:S9-S16.
65.
Wigler M, Levy D, Perucho M. 1981. The somatic replication of DNA methylation. Cell24:33-40.
66.
Wilson VL, Jones PA. 1983. DNA methylation decreases in aging but not in immortal cells. Science220:1055-1057.
67.
Wolffe AP, Matzke MA. 1999. Epigenetics: regulation through repression. Science286:481-486.
68.
Yang X, Yan L, Davidson NE. 2001. DNA methylation in breast cancer. Endocr Relat Cancer8:115-127.
69.
Ying AK, Hassanain HH, Roos CM, Smiraglia DJ, Issa JJ, Michler RE, Caligiuri M, Plass C, Goldschmidt-Clermont PJ. 2000. Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells. Cardiovasc Res46:172-179.
70.
Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U. 2002. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med252:247-254.